Achillestendinopathy Treated With Proximal Medial Gastrocnemius Recession
Proximal Medial Gastrocnemius Recession for Chronic Mid-Portion Achilles Tendinopathy; A Multicenter, Prospective Cohort Study.
1 other identifier
interventional
60
1 country
2
Brief Summary
This is a prospective cohort study that will follow 60 patients treated with Proximal Medial Gastrocnemius Recession for Chronic Mid-Portion Achilles Tendinopathy for 5 years postoperatively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2021
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 21, 2021
CompletedStudy Start
First participant enrolled
December 31, 2021
CompletedFirst Posted
Study publicly available on registry
January 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMarch 8, 2024
March 1, 2024
3.4 years
October 21, 2021
March 6, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
VISA-A - Victorian Institute of Sport Assessment- Achilles Questionnaire
A PROM validated for patients with achilles tendon disorders
Baseline
VISA-A - Victorian Institute of Sport Assessment- Achilles Questionnaire
A PROM validated for patients with achilles tendon disorders
3 months
VISA-A - Victorian Institute of Sport Assessment- Achilles Questionnaire
A PROM validated for patients with achilles tendon disorders
1 year
VISA-A - Victorian Institute of Sport Assessment- Achilles Questionnaire
A PROM validated for patients with achilles tendon disorders
2 years
VISA-A - Victorian Institute of Sport Assessment- Achilles Questionnaire
A PROM validated for patients with achilles tendon disorders
5 years
Secondary Outcomes (13)
Achilles Function Test battery
Baseline, 3 months, 2 years
Ankle Dorsiflexion pre and postoperatively
Baseline, 3 months, 2 years
MRI findings pre inclusion versus after 2 years.
Baseline, 2years
VAS
Baseline, 3 months, 1 year, 2 years, 5 years
Eq-5D
Baseline, 3 months, 1 year, 2 years, 5 years
- +8 more secondary outcomes
Study Arms (1)
Proximal Medial Gastrocnemius Recession Surgery
EXPERIMENTALPatients will be operated with Proximal Medial Gastrocnemius Recession Surgery (PMGR) ad modum Barouk.
Interventions
. A 3-4 cm transverse skin incision is made in the popliteal fossa, the superficial fascia is opened, and the medial gastrocnemius with its tendon (aponeurosis) is located. The tendon is then cut while lifting it with clamps, and care is taken to cut only the white tendon while sparing the underlying muscle. While performing a dorsiflexion movement of the ankle, careful palpation of the muscle is done to ensure that all tendon strands are cut completely. The incision is closed in layers, and only soft dressings applied
Eligibility Criteria
You may qualify if:
- Age 18-75 years.
- Diagnosis CMPAT verified clinically by orthopedic surgeon. Symptoms must include mid-portion pain in the Achilles, swelling and reduced tolerance for weightbearing.
- Verified diagnosis with MRI findings representing pathologic processes of tendon degeneration and repair (13). MRI no older than 12 months.
- Duration of symptoms must be at least 12 months.
- At least three months of conventional physical therapy with eccentric training must have been tried without providing relief of symptoms.
You may not qualify if:
- Previous history of complete Achilles tendon rupture.
- Other combined pathologies in the Achilles tendon of calf (Sequela from trauma, infections, cancer etc.).
- Insertional Achilles tendinopathy.
- Previously undergone surgery in affected tendon.
- Patients with severe talocrural pathology or serious malalignment of foot and ankle.
- Severely reduced peripheral circulation.
- History of alcoholism, drug abuse, psychological or other emotional problems likely to jeopardize informed consent.
- Patients with a contraindication/non-compliance for MRI examination.
- History of allergic reaction/anaphylactic reaction to local anesthetics.
- Not able to read and/or speak a Scandinavian language or English adequately.
- Other serious comorbidity that makes surgery unadvisable.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ostfold Hospital Trustlead
- Oslo University Hospitalcollaborator
Study Sites (2)
Oslo University Hospital, Orthopedic Department Ullevål
Oslo, 1714, Norway
Østfold Hospital Trust
Sarpsborg, Østfold fylke, 1714, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marius Molund, PhD
Ostfold Hospital Trust
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 21, 2021
First Posted
January 5, 2022
Study Start
December 31, 2021
Primary Completion
May 31, 2025
Study Completion
December 31, 2025
Last Updated
March 8, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share